4/12
01:57 pm
envb
What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock [Yahoo! Finance]
Low
Report
What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock [Yahoo! Finance]
3/26
07:17 am
envb
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 [Yahoo! Finance]
Low
Report
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 [Yahoo! Finance]
3/26
07:00 am
envb
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
Low
Report
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
3/19
08:47 am
envb
Enveric gains on out-licensing deal of new chemical entities for joint disease treatments [Seeking Alpha]
High
Report
Enveric gains on out-licensing deal of new chemical entities for joint disease treatments [Seeking Alpha]
3/19
07:17 am
envb
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease [Yahoo! Finance]
High
Report
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease [Yahoo! Finance]
3/19
07:00 am
envb
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
Medium
Report
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
3/12
07:17 am
envb
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets [Yahoo! Finance]
High
Report
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets [Yahoo! Finance]
3/12
07:00 am
envb
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets
Medium
Report
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets
2/29
07:10 am
envb
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds [Yahoo! Finance]
Medium
Report
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds [Yahoo! Finance]
2/29
07:00 am
envb
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
Low
Report
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
2/26
08:18 am
envb
CORRECTION – Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB) [Yahoo! Finance]
Medium
Report
CORRECTION – Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB) [Yahoo! Finance]
2/23
08:15 am
envb
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property [Yahoo! Finance]
Medium
Report
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property [Yahoo! Finance]
2/23
08:00 am
envb
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
Medium
Report
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
2/21
08:11 am
envb
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders [Yahoo! Finance]
Low
Report
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders [Yahoo! Finance]
2/21
08:00 am
envb
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders
Medium
Report
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders
1/30
08:06 am
envb
Enveric Biosciences, Inc. (NASDAQ: ENVB) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Enveric Biosciences, Inc. (NASDAQ: ENVB) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.